Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Hamidi

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|July 6, 2023
Recent advances in anaplastic thyroid cancer managementSarah Hamidi, Anastasios Maniakas
Annales D'Endocrinologie|February 11, 2024
RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directionsSarah Hamidi, Mimi I Hu
JCEM Case Reports|July 30, 2024
Paraneoplastic Diarrhea From Medullary Thyroid Carcinoma Resolved With Yttrium-90 Radioembolization of Liver MetastasesSarah Hamidi, Armeen Mahvash, Mimi I Hu
Endocrinology and Metabolism Clinics of North America|July 27, 2025
Advances in Anaplastic Thyroid Cancer TreatmentSarah Hamidi, Anastasios Maniakas, Maria E Cabanillas
Global Heart|May 11, 2026
Climate Change and Cardiovascular Health: Advancing Resilient Action Beyond COP30Poornima Prabhakaran, César Berenstein, Sarah Hamidi, et al.
JCEM Case Reports|January 27, 2025
Recurrent Poorly Differentiated Thyroid Cancer Successfully Treated With Radiation and ImmunotherapySarah Hamidi, Matthew S Ning, Jack Phan, et al.
Journal of the Endocrine Society|April 27, 2022
Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side EffectsSarah Hamidi, Andrée Boucher, Bernard Lemieux, et al.
Frontiers in Endocrinology|July 12, 2023
Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistanceSarah Hamidi, Marie-Claude Hofmann, Priyanka C Iyer, et al.
The Journal of Clinical Endocrinology and Metabolism|March 19, 2025
Approach to the Patient: Hereditary Medullary Thyroid CarcinomaOmair A Shariq, Steven G Waguespack, Sarah Hamidi, et al.
Thyroid : Official Journal of the American Thyroid Association|January 16, 2024
Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF<sup>V600E</sup>-Mutated Anaplastic Thyroid CarcinomaSarah Hamidi, Priyanka C Iyer, Ramona Dadu, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Current Opinion in Endocrinology, Diabetes, and Obesity|July 6, 2023
Recent advances in anaplastic thyroid cancer managementSarah Hamidi, Anastasios Maniakas
Annales D'Endocrinologie|February 11, 2024
RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directionsSarah Hamidi, Mimi I Hu
JCEM Case Reports|July 30, 2024
Paraneoplastic Diarrhea From Medullary Thyroid Carcinoma Resolved With Yttrium-90 Radioembolization of Liver MetastasesSarah Hamidi, Armeen Mahvash, Mimi I Hu
Endocrinology and Metabolism Clinics of North America|July 27, 2025
Advances in Anaplastic Thyroid Cancer TreatmentSarah Hamidi, Anastasios Maniakas, Maria E Cabanillas
Global Heart|May 11, 2026
Climate Change and Cardiovascular Health: Advancing Resilient Action Beyond COP30Poornima Prabhakaran, César Berenstein, Sarah Hamidi, et al.
JCEM Case Reports|January 27, 2025
Recurrent Poorly Differentiated Thyroid Cancer Successfully Treated With Radiation and ImmunotherapySarah Hamidi, Matthew S Ning, Jack Phan, et al.
Journal of the Endocrine Society|April 27, 2022
Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side EffectsSarah Hamidi, Andrée Boucher, Bernard Lemieux, et al.
Frontiers in Endocrinology|July 12, 2023
Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistanceSarah Hamidi, Marie-Claude Hofmann, Priyanka C Iyer, et al.
The Journal of Clinical Endocrinology and Metabolism|March 19, 2025
Approach to the Patient: Hereditary Medullary Thyroid CarcinomaOmair A Shariq, Steven G Waguespack, Sarah Hamidi, et al.
Thyroid : Official Journal of the American Thyroid Association|January 16, 2024
Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF<sup>V600E</sup>-Mutated Anaplastic Thyroid CarcinomaSarah Hamidi, Priyanka C Iyer, Ramona Dadu, et al.
Pageof 3